The association of anti-tumor necrosis factor and thiopurine therapy with the risk of lymphoma among Inflammatory Bowel Disease patients: A nation-wide study from the epi-IIRN

被引：0

作者：

Waterman, M. ^{[1
]}

Lavi, I. ^{[2
]}

Harel, S. ^{[3
]}

Focht, G. ^{[3
]}

Weisband, J. Loewenberg ^{[4
]}

Greenfeld, S. ^{[5
]}

Kariv, R. ^{[5
]}

Ledderman, N. ^{[6
]}

Matz, E. ^{[7
]}

Keinan-Boker, L. ^{[8
]}

Eizenstein, S. ^{[9
]}

Dotan, I. ^{[10
]}

Turner, D. ^{[3
]}

Levi, Z. ^{[10
]}

机构：

[1] Technion Israel Inst Technol, Dept Gastroenterol, Rambam Hlth Care Campus, Rappaport Fac Med, Haifa, Israel

[2] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel

[3] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel

[4] Clalit Hlth Serv, Clalit Res Inst, Chief Phys Off, Tel Aviv, Israel

[5] Tel Aviv Univ, Maccabi Hlth Serv, Sackler Fac Med, Tel Aviv, Israel

[6] Meuhedet, Hlth Serv, Tel Aviv, Israel

[7] Leumit, Hlth Serv, Tel Aviv, Israel

[8] Univ Haifa, Sch Publ Hlth, Haifa, Israel

[9] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel

[10] Tel Aviv Univ, Div Gastroenterol, Rabin Med Ctr Petah Tikva, Sackler Fac Med, Tel Aviv, Israel

来源：

JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP72

引用

页码：I115 / I1116

页数：2

共 50 条

[21] Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN
Gorelik, Yuri
Freilich, Shay
Gerassy-Vainberg, Shiran
Pressman, Sigal
Friss, Chagit
Blatt, Alexandera
Focht, Gili
Weisband, Yiska Loewenberg
Greenfeld, Shira
Kariv, Revital
Lederman, Nathan
Dotan, Iris
Geva-Zatorsky, Naama
Shen-Orr, Shai Shlomo
Kashi, Yechezkel
Chowers, Yehuda
[J]. GUT, 2022, 71 (02) : 287 - 295
[22] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
Lew, Daniel
Yoon, Soon Man
Yan, Xiaofei
Robbins, Lori
Haritunians, Talin
Liu, Zhenqiu
Li, Dalin
McGovern, Dermot P. B.
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
[23] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
Daniel Lew
Soon Man Yoon
Xiaofei Yan
Lori Robbins
Talin Haritunians
Zhenqiu Liu
Dalin Li
Dermot PB McGovern
[J]. World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
[24] Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease
Sumida, Keiichi
Shrestha, Prabin
Mallisetty, Yamini
Thomas, Fridtjof
Gyamlani, Geeta
Streja, Elani
Kalantar-Zadeh, Kamyar
Kovesdy, Csaba P.
[J]. JAMA NETWORK OPEN, 2024, 7 (04)
[25] Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
Ferraro, Sara
Leonardi, Luca
Convertino, Irma
Blandizzi, Corrado
Tuccori, Marco
[J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
[26] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
Calloway, Alexis
Dalal, Robin
Beaulieu, Dawn B.
Duley, Caroline
Annis, Kimberly
Gaines, Lawrence
Slaughter, Chris
Schwartz, David A.
Horst, Sara
[J]. DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
[27] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
Cheon, Jae Hee
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
[28] Pulmonary lesions in patients with inflammatory bowel disease - the baseline and under anti-tumor necrosis factor therapy
Borisov, Sergey
Frolova, Ksenia
[J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[29] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
Alexis Calloway
Robin Dalal
Dawn B. Beaulieu
Caroline Duley
Kimberly Annis
Lawrence Gaines
Chris Slaughter
David A. Schwartz
Sara Horst
[J]. Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
[30] Malignancy Outcomes in Inflammatory Bowel Disease Patients on Immune Modulators and Anti-Tumor Necrosis Factor Therapy
Patel, Umangi
Lichtenstein, Gary
Scott, Frank
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S484 - S484

← 1 2 3 4 5 →